Robin Howard W's Form 4 filing
Nektar Therapeutics (NKTR) · filed Sep 8, 2025
- Accession no.
- 0000950170-25-113691
- Filed
- Sep 8, 2025
- Trade date
- Sep 4-5, 2025
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 7 non-derivative transactions and 0 derivative transactions. Open-market sales total $431.0K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Robin Howard WCIK 0001206869 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 4, 2025 | Common Stock | SSaleDisposed | −1,923 | $32.37 | −$62,247.51 | 65,917 | Direct | |
| Sep 4, 2025 | Common Stock | SSaleDisposed | −1,496 | $33.54 | −$50,175.84 | 64,421 | Direct | |
| Sep 4, 2025 | Common Stock | SSaleDisposed | −613 | $34.40 | −$21,087.2 | 63,808 | Direct | |
| Sep 4, 2025 | Common Stock | SSaleDisposed | −1,134 | $35.80 | −$40,597.2 | 62,674 | Direct | |
| Sep 5, 2025 | Common Stock | SSaleDisposed | −3,304 | $37.87 | −$125,122.48 | 59,370 | Direct | |
| Sep 5, 2025 | Common Stock | SSaleDisposed | −2,226 | $38.82 | −$86,413.32 | 57,144 | Direct | |
| Sep 5, 2025 | Common Stock | SSaleDisposed | −1,136 | $39.89 | −$45,315.04 | 56,008 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.